Creative Planning Edwards Lifesciences Corp Transaction History

Creative Planning

$116 Billion
Q2 2025

A detailed history of Creative Planning transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Creative Planning holds 389,409 shares of EW stock, worth $32.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

389,409

Previous 374,073 4.1%

Holding current value

$32.1 Million

Previous $27.1 Million 12.33%

% of portfolio

0.03%

Previous 0.03%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$67.07 - $78.22 $1.03 Million - $1.2 Million	15,336 Added 4.1%	389,409 $30.5 Million
Q1 2025 May 15, 2025	BUY	$67.95 - $76.19 $668,831 - $749,938	9,843 Added 2.7%	374,073 $27.1 Million
Q4 2024 Feb 14, 2025	SELL	$64.54 - $75.92 $1.32 Million - $1.55 Million	-20,399 Reduced 5.3%	364,230 $27 Million
Q3 2024 Oct 11, 2024	SELL	$59.7 - $93.78 $291,873 - $458,490	-4,889 Reduced 1.26%	384,629 $25.4 Million
Q2 2024 Aug 15, 2024	BUY	$84.3 - $94.31 $73,088 - $81,766	867 Added 0.22%	389,518 $36 Million
Q1 2024 May 10, 2024	BUY	$72.54 - $95.56 $12.9 Million - $16.9 Million	177,216 Added 83.82%	388,651 $37.1 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $2.83 Million - $3.56 Million	45,794 Added 27.65%	211,435 $16.1 Million
Q3 2023 Nov 16, 2023	SELL	$69.28 - $93.38 $365,729 - $492,953	-5,279 Reduced 3.09%	165,641 $11.5 Million
Q2 2023 Jul 21, 2023	BUY	$81.41 - $94.33 $736,923 - $853,875	9,052 Added 5.59%	170,920 $16.1 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $360,012 - $409,704	4,848 Added 3.09%	161,868 $13.4 Million
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $582,599 - $745,863	8,530 Added 5.74%	157,020 $11.7 Million
Q3 2022 Nov 03, 2022	BUY	$82.37 - $107.29 $695,861 - $906,385	8,448 Added 6.03%	148,490 $12.3 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $210,454 - $312,080	2,433 Added 1.77%	140,042 $13.3 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $1.7 Million - $2.14 Million	16,689 Added 13.8%	137,609 $16.2 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $399,738 - $491,095	3,758 Added 3.21%	120,920 $15.7 Million
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $140,575 - $167,676	-1,366 Reduced 1.15%	117,162 $13.3 Million
Q2 2021 Aug 04, 2021	SELL	$83.84 - $104.76 $178,160 - $222,615	-2,125 Reduced 1.76%	118,528 $12.3 Million
Q1 2021 Apr 30, 2021	SELL	$78.68 - $90.67 $131,159 - $151,146	-1,667 Reduced 1.36%	120,653 $10.1 Million
Q4 2020 Jan 29, 2021	BUY	$71.69 - $91.23 $476,595 - $606,497	6,648 Added 5.75%	122,320 $11.2 Million
Q3 2020 Nov 05, 2020	BUY	$67.19 - $87.44 $443,386 - $577,016	6,599 Added 6.05%	115,672 $9.23 Million
Q2 2020 Jul 23, 2020	BUY	$57.54 - $76.95 $4.21 Million - $5.62 Million	73,084 Added 203.07%	109,073 $7.54 Million
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $42,923 - $66,339	-819 Reduced 2.23%	35,989 $6.79 Million
Q4 2019 Jan 30, 2020	BUY	$71.7 - $82.09 $188,284 - $215,568	2,626 Added 7.68%	36,808 $8.59 Million
Q3 2019 Nov 01, 2019	BUY	$61.55 - $75.43 $125,192 - $153,424	2,034 Added 6.33%	34,182 $7.52 Million
Q2 2019 Jul 26, 2019	SELL	$55.74 - $64.41 $85,114 - $98,354	-1,527 Reduced 4.53%	32,148 $5.94 Million
Q1 2019 Apr 24, 2019	SELL	$47.89 - $64.05 $47,602 - $63,665	-994 Reduced 2.87%	33,675 $6.44 Million
Q4 2018 Feb 01, 2019	BUY	$46.41 - $56.94 $510 - $626	11 Added 0.03%	34,669 $5.31 Million
Q3 2018 Oct 25, 2018	SELL	$45.7 - $58.03 $2,147 - $2,727	-47 Reduced 0.14%	34,658 $6.03 Million
Q2 2018 Jul 20, 2018	BUY	$42.45 - $51.3 $36,040 - $43,553	849 Added 2.51%	34,705 $5.05 Million
Q1 2018 Apr 18, 2018	BUY	$37.19 - $47.45 $18,669 - $23,819	502 Added 1.51%	33,856 $4.72 Million
Q4 2017 Jan 17, 2018	BUY	$33.79 - $39.39 $19,361 - $22,570	573 Added 1.75%	33,354 $3.76 Million
Q3 2017 Oct 17, 2017	BUY	$36.29 - $38.83 $1.19 Million - $1.27 Million	32,781	32,781 $3.58 Million

Others Institutions Holding EW

# of Institutions

1,457

Shares Held

487M

Call Options Held

2.76M

Put Options Held

1.54M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $51B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Edwards Lifesciences Corp Transaction History